Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Artificial heart study aims to keep patients alive until transplant

NCT ID NCT05474092

First seen Feb 01, 2026 · Last updated May 24, 2026 · Updated 14 times

Summary

This study is for people with end-stage heart failure who need a total artificial heart while waiting for a heart transplant. The Aeson device is already approved in Europe, and this research confirms it works well in everyday hospital use. About 95 participants will be followed to see how many survive on the device and how their quality of life changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • HZ Dresden

    RECRUITING

    Dresden, 01307, Germany

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.